Autologous Mesenchymal Stromal Cells Prevent Transfusion-elicited Sensitization and Upregulate Transitional and Regulatory B Cells

Background. We hypothesized that immunomodulatory properties of mesenchymal stromal cells (MSC) may be considered for desensitization. Methods. Autologous or allogeneic bone marrow derived MSC were infused via tail vein at 0.5 M (0.5 × 106), 1 M, or 2 M cells/dose on days −2, 3, 6, 9, 12 (prevention...

Full description

Bibliographic Details
Main Authors: Zijian Zhang, MD, Nancy A. Wilson, PhD, Raghavan Chinnadurai, PhD, Sarah E. Panzer, MD, Robert R. Redfield, III, MD, Shannon R. Reese, MS, Jacques Galipeau, MD, Arjang Djamali, MD
Format: Article
Language:English
Published: Wolters Kluwer 2018-09-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000000827